DD264851A5 - Verfahren zur herstellung einer zusammensetzung - Google Patents

Verfahren zur herstellung einer zusammensetzung Download PDF

Info

Publication number
DD264851A5
DD264851A5 DD87310746A DD31074687A DD264851A5 DD 264851 A5 DD264851 A5 DD 264851A5 DD 87310746 A DD87310746 A DD 87310746A DD 31074687 A DD31074687 A DD 31074687A DD 264851 A5 DD264851 A5 DD 264851A5
Authority
DD
German Democratic Republic
Prior art keywords
composition
general formula
methyl
pct
added
Prior art date
Application number
DD87310746A
Other languages
German (de)
English (en)
Inventor
Gyoergy Bodo
Jozsef Knoll
Eva Somfai
Sandor Virag
Ferenc Zak
Original Assignee
��������@��@����������@��@��@����������@���������k��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ��������@��@����������@��@��@����������@���������k�� filed Critical ��������@��@����������@��@��@����������@���������k��
Publication of DD264851A5 publication Critical patent/DD264851A5/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
DD87310746A 1986-12-19 1987-12-18 Verfahren zur herstellung einer zusammensetzung DD264851A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU865338A HU197510B (en) 1986-12-19 1986-12-19 Process for producing pharmaceutical composition containing phenyl-alkyl-amine derivatives, against motion-sick

Publications (1)

Publication Number Publication Date
DD264851A5 true DD264851A5 (de) 1989-02-15

Family

ID=10970131

Family Applications (1)

Application Number Title Priority Date Filing Date
DD87310746A DD264851A5 (de) 1986-12-19 1987-12-18 Verfahren zur herstellung einer zusammensetzung

Country Status (26)

Country Link
US (1) US4925878A (es)
EP (1) EP0294441B1 (es)
JP (1) JP2534553B2 (es)
AT (1) ATE82847T1 (es)
BG (1) BG51918A1 (es)
CY (1) CY1740A (es)
CZ (1) CZ277831B6 (es)
DD (1) DD264851A5 (es)
DE (1) DE3782935T2 (es)
DK (1) DK464788A (es)
ES (1) ES2009228A6 (es)
FI (1) FI883837A (es)
GE (1) GEP19970949B (es)
GR (1) GR871953B (es)
HK (1) HK105193A (es)
HU (1) HU197510B (es)
IL (1) IL84786A (es)
LT (1) LT4007B (es)
LV (1) LV10185B (es)
MD (1) MD408C2 (es)
MX (1) MX9203088A (es)
PT (1) PT86406B (es)
RU (1) RU1825314C (es)
SK (1) SK278500B6 (es)
UA (1) UA19281A1 (es)
WO (1) WO1988004552A1 (es)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4861800A (en) * 1987-08-18 1989-08-29 Buyske Donald A Method for administering the drug deprenyl so as to minimize the danger of side effects
CS269271B1 (en) * 1988-05-30 1990-04-11 Hajicek Josef Method of selegiline's hydrochloride production
HU208484B (en) * 1988-08-17 1993-11-29 Chinoin Gyogyszer Es Vegyeszet Process for producing pharmaceutical composition containing acid additional salt of selegilin as active component for treating schisofrenia
US5744500A (en) 1990-01-03 1998-04-28 Teva Pharmaceutical Industries, Ltd. Use of R-enantiomer of N-propargyl-1-aminoindan, salts, and compositions thereof
US5844003A (en) * 1991-04-04 1998-12-01 Innovations Foundation Use of deprenyl compounds to maintain, prevent loss, or recover nerve cell function
CA2107552C (en) * 1991-04-04 2001-08-28 William G. Tatton Use of deprenyl to maintain, prevent loss, or recover nerve cell function
US5767164A (en) * 1991-04-04 1998-06-16 Innovations Foundation Use of deprenyl to rescue damaged nerve cells
US5444095A (en) * 1991-04-04 1995-08-22 University Of Toronto, Innovations Foundation Use of deprenyl to rescue damaged nerve cells
HUT63579A (en) * 1991-12-20 1993-09-28 Chinoin Gyogyszer Es Vegyeszet Process for producing double-phase pharmaceutical compositions suitable for treating diseases occurring during neurodegenerative processes
US5242950A (en) * 1992-04-23 1993-09-07 Somerset Pharmaceuticals, Inc. Treatment of macular degeneration
US5817336A (en) * 1993-04-02 1998-10-06 Orion-Yhtyma Oy Composition containing selegiline
FR2704756B1 (fr) * 1993-05-04 1995-07-28 Sanofi Elf Utilisation de la sélégiline en médecine vétérinaire.
ES2149850T3 (es) * 1993-05-04 2000-11-16 Ceva Sante Animale Utilizacion de la selegilina en medicina veterinaria.
GB2280604B (en) * 1993-07-02 1997-04-30 Resource Medical Limited Processing of active agents
ATE199829T1 (de) * 1994-06-03 2001-04-15 Thejmde Trust Meta substituierte arylalkylamine und therapeutische und diagnostische verwendung davon
US6319954B1 (en) 1995-01-13 2001-11-20 Somerset Pharmaceuticals, Inc. S-(+)-desmethylselegiline and its use in the therapeutic methods and pharmaceutical compositions
US6348208B1 (en) 1995-01-13 2002-02-19 Somerset Pharmaceuticals, Inc. Methods and pharmaceutical compositions employing desmethylselegiline
US6033682A (en) 1995-01-13 2000-03-07 Somerset Pharmaceuticals, Inc. S(+) desmethylselegiline and its use in therapeutic methods and pharmaceutical compositions
US6299901B1 (en) 1995-01-13 2001-10-09 Somerset Pharmaceuticals, Inc. Methods and pharmaceutical compositions employing desmethylselegiline
EP0808160A1 (en) 1995-02-10 1997-11-26 The University Of Toronto Innovations Foundation Deprenyl compounds for treatment of glaucoma
AU702161B2 (en) * 1995-03-02 1999-02-18 R.P. Scherer Limited Pharmaceutical compositions comprising monoamine oxidase B inhibitors
DE19716905C1 (de) * 1997-04-22 1998-08-27 Iip Inst Fuer Ind Pharmazie Fo Stabile, wäßrige Lösung auf der Grundlage von Selegilin und Vorrichtung zu ihrer Verabreichung
US6042533A (en) 1998-07-24 2000-03-28 Kania; Bruce Apparatus and method for relieving motion sickness
US6197329B1 (en) 1999-05-03 2001-03-06 Drugtech Corporation Anti-nausea compositions and methods
US6443913B1 (en) 2000-03-07 2002-09-03 Bruce Kania Apparatus and method for relieving motion sickness
US6497649B2 (en) * 2001-01-21 2002-12-24 University Of Washington Alleviating motion, simulator, and virtual environmental sickness by presenting visual scene components matched to inner ear vestibular sensations
US7128705B2 (en) * 2002-11-26 2006-10-31 Artis Llc Motion-coupled visual environment for prevention or reduction of motion sickness and simulator/virtual environment sickness
AT16235U1 (de) * 2018-06-21 2019-04-15 Dr Reinhart Jarisch Kaugummi enthaltend Vitamin C

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1031425A (en) * 1962-03-30 1966-06-02 Chinoin Gyogyszer Es Vegyeszet New aralkylamines and their preparation
DE1227447B (de) * 1962-03-30 1966-10-27 Chinoin Gyogyszer Es Vegyeszet Verfahren zur Herstellung von Phenylisopropylaminen
DK0564802T3 (da) 1992-04-10 1997-03-10 Schott Glaswerke Bly- og bariumfrit krystalglas med høj lystransmission

Also Published As

Publication number Publication date
GEP19970949B (en) 1997-03-31
US4925878A (en) 1990-05-15
PT86406A (en) 1988-01-01
HUT45196A (en) 1988-06-28
HU197510B (en) 1989-04-28
LV10185A (lv) 1994-10-20
JPH01501626A (ja) 1989-06-08
CS8709491A1 (en) 1990-05-14
LV10185B (en) 1995-04-20
JP2534553B2 (ja) 1996-09-18
MD408C2 (ro) 1996-07-31
EP0294441A1 (en) 1988-12-14
GR871953B (en) 1988-04-19
UA19281A1 (uk) 1997-12-25
HK105193A (en) 1993-10-15
CZ277831B6 (en) 1993-06-16
PT86406B (pt) 1990-11-20
DK464788D0 (da) 1988-08-18
MX9203088A (es) 1992-07-01
BG51918A1 (en) 1993-11-15
ES2009228A6 (es) 1989-09-16
DE3782935T2 (de) 1993-04-08
CY1740A (en) 1995-10-20
ATE82847T1 (de) 1992-12-15
DE3782935D1 (de) 1993-01-14
RU1825314C (ru) 1993-06-30
LTIP1849A (en) 1995-08-25
EP0294441B1 (en) 1992-12-02
FI883837A0 (fi) 1988-08-18
DK464788A (da) 1988-08-18
FI883837A (fi) 1988-08-18
SK278500B6 (en) 1997-05-14
LT4007B (en) 1996-07-25
IL84786A (en) 1991-08-16
WO1988004552A1 (en) 1988-06-30

Similar Documents

Publication Publication Date Title
DD264851A5 (de) Verfahren zur herstellung einer zusammensetzung
DE69435095T2 (de) Neue Behandlungsmethoden durch Verwendung von Phenethylaminderivaten
DE3915347C2 (de) Harzadsorbate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Präparate
DE60109589T2 (de) Pharmazeutische zusammensetzung zur behandlung von akutem schmerz, chronischem schmerz und/oder neuropathischem schmerz und migräne
DE3709621A1 (de) Therapeutisches mittel
CH638803A5 (de) Verfahren zur herstellung neuer 4-amino-4-arylcyclohexanon-ketale.
DE3922666A1 (de) Antitumor-mittel
DE69926804T2 (de) Vorrichtungen zur behandlung und diagnose des restless leg syndroms
EP1056448B1 (de) Pharmazeutische kombinationen mit tramadol
DE3415394A1 (de) Medikament gegen ovarialinsuffizienz
DE60127712T2 (de) Selektive dopamin-d4-rezeptoragonisten zur behandlung von sexuellen dysfunktionen
EP0035597A2 (de) Pharmazeutische Zubereitungen
DE2823268C2 (es)
DE2755017C2 (es)
DE2831728C2 (de) Arzneimittel zur Behandlung von Kopfschmerzen
EP0192098B1 (de) Verwendung des 2-Amino-6-allyl-5,6,7,8-tetrahydro-4H-thiazolo[4,5-d]azepins zur Herstellung eines zur Behandlung der Parkinsonschen Erkrankung bzw. des Parkinsonismus geeigneten Arzneimittels
DE2810051A1 (de) Zubereitung fuer die behandlung von asthma
DE2916880C2 (de) Arzneimittel mit sedativer und schlafinduzierender Wirkung
US4188404A (en) Treatment of symptoms of aging
EP0417637A2 (de) Verwendung von Dopamin-Autorezeptor-Agonisten bei der Behandlung von Drogenabhängigkeit
DE2532180C2 (de) Verwendung von Etozolin bei der Bekämpfung der Hypertonie
AT227871B (de) Verfahren zur Herstellung von ganz oder teilweise entbittertern Dextromethorphan-Präparaten
DE2823267A1 (de) Antihypertensive praeparate
DE1967186C3 (de) Arzneimittel, enthaltend 4,4-Diarylpiperidine
CH673654A5 (es)

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee